BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31520260)

  • 21. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
    Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
    Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?
    Weng CH; Wu RC; Chen SJ; Chen HC; Tan KT; Lee YS; Huang SS; Yang LY; Wang CJ; Chou HH; Chao AS; Chao A; Lai CH
    J Mol Med (Berl); 2021 Jul; 99(7):959-966. PubMed ID: 33768299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality.
    Anglesio MS; Wang YK; Maassen M; Horlings HM; Bashashati A; Senz J; Mackenzie R; Grewal DS; Li-Chang H; Karnezis AN; Sheffield BS; McConechy MK; Kommoss F; Taran FA; Staebler A; Shah SP; Wallwiener D; Brucker S; Gilks CB; Kommoss S; Huntsman DG
    J Natl Cancer Inst; 2016 Jun; 108(6):djv428. PubMed ID: 26832771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian involvement in endometrioid adenocarcinoma of uterus.
    Lin KY; Miller DS; Bailey AA; Andrews SJ; Kehoe SM; Richardson DL; Lea JS
    Gynecol Oncol; 2015 Sep; 138(3):532-5. PubMed ID: 26186908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synchronous squamous cell carcinoma of the endometrium and endometrioid adenocarcinoma of the ovary.
    Grigoriadis C; Androutsopoulos G; Zygouris D; Arnogiannaki N; Terzakis E
    Eur J Gynaecol Oncol; 2012; 33(6):666-8. PubMed ID: 23327069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma.
    Hemminki K; Aaltonen L; Li X
    Cancer; 2003 May; 97(10):2432-9. PubMed ID: 12733142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival and prognostic factors in patients with synchronous ovarian and endometrial cancers and endometrial cancers metastatic to the ovaries.
    Ayhan A; Guvenal T; Coskun F; Basaran M; Salman MC
    Eur J Gynaecol Oncol; 2003; 24(2):171-4. PubMed ID: 12701972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors predicting recurrence in patients with stage IA endometrioid endometrial cancer: what is the importance of LVSI?
    Ureyen I; Karalok A; Turkmen O; Kimyon G; Akdas YR; Akyol A; Tasci T; Turan T
    Arch Gynecol Obstet; 2020 Mar; 301(3):737-744. PubMed ID: 31883046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Synchronous primary cancer of the endometrium and ovary].
    Lou HM; Lou HK; Wu MJ
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):617-20. PubMed ID: 17236559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical and prognostic features of ovarian endometrioid carcinoma with synchronous endometrial lesions].
    Yao LQ; Zhou L; Dai L; Ye X; Zhu HL; Cheng HY; Ma RQ; Cui H; Chang XH
    Zhonghua Fu Chan Ke Za Zhi; 2021 Mar; 56(3):200-207. PubMed ID: 33874715
    [No Abstract]   [Full Text] [Related]  

  • 32. Synchronous ovarian endometrioid adenocarcinoma with a functioning stroma and endometrial endometrioid adenocarcinoma by different loss of heterozygosity findings.
    Takai N; Kai K; Tsuno A; Nasu K; Kashima K; Narahara H
    Arch Gynecol Obstet; 2011 Oct; 284(4):951-5. PubMed ID: 21046134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.
    Schultheis AM; Ng CK; De Filippo MR; Piscuoglio S; Macedo GS; Gatius S; Perez Mies B; Soslow RA; Lim RS; Viale A; Huberman KH; Palacios JC; Reis-Filho JS; Matias-Guiu X; Weigelt B
    J Natl Cancer Inst; 2016 Jun; 108(6):djv427. PubMed ID: 26832770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinicopathological characteristics and survival outcomes of endometrial carcinoma coexisting with or arising in adenomyosis: A pilot study.
    Chao X; Wu M; Ma S; Tan X; Zhong S; Bi Y; Wu H; Lang J; Li L
    Sci Rep; 2020 Apr; 10(1):5984. PubMed ID: 32249826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
    Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S
    Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic analysis for Chinese patients with stage I ovarian endometrioid carcinoma.
    Zhao Y; Wang S; Qu YM; Ji YT; Shen K; Lang JH
    J Ovarian Res; 2017 Sep; 10(1):63. PubMed ID: 28923080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coexisting endometrial and ovarian carcinomas: a retrospective clinicopathological study.
    Caldarella A; Crocetti E; Taddei GL; Paci E
    Pathol Res Pract; 2008; 204(9):643-8. PubMed ID: 18472354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic insight of simultaneously detected primary endometrial and ovarian carcinomas.
    Rodolakis A; Thomakos N; Akrivos N; Sotiropoulou M; Ioannidis I; Haidopoulos D; Vlachos G; Antsaklis A
    Arch Gynecol Obstet; 2012 Mar; 285(3):817-21. PubMed ID: 21842403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasion patterns in stage I endometrioid and mucinous ovarian carcinomas: a clinicopathologic analysis emphasizing favorable outcomes in carcinomas without destructive stromal invasion and the occasional malignant course of carcinomas with limited destructive stromal invasion.
    Chen S; Leitao MM; Tornos C; Soslow RA
    Mod Pathol; 2005 Jul; 18(7):903-11. PubMed ID: 15696121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.